Jes Olesen, Hans-Christoph Diener, Ingo W Husstedt, Peter J Goadsby, David Hall, Ulrich Meier, Stephane Pollentier, Lynna M Lesko. N Engl J Med 2004
Times Cited: 868
Times Cited: 868
Times Cited
Times Co-cited
Similarity
Pathophysiology of Migraine: A Disorder of Sensory Processing.
Peter J Goadsby, Philip R Holland, Margarida Martins-Oliveira, Jan Hoffmann, Christoph Schankin, Simon Akerman. Physiol Rev 2017
Peter J Goadsby, Philip R Holland, Margarida Martins-Oliveira, Jan Hoffmann, Christoph Schankin, Simon Akerman. Physiol Rev 2017
33
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.
P J Goadsby, L Edvinsson, R Ekman. Ann Neurol 1990
P J Goadsby, L Edvinsson, R Ekman. Ann Neurol 1990
32
CGRP as the target of new migraine therapies - successful translation from bench to clinic.
Lars Edvinsson, Kristian Agmund Haanes, Karin Warfvinge, Diana N Krause. Nat Rev Neurol 2018
Lars Edvinsson, Kristian Agmund Haanes, Karin Warfvinge, Diana N Krause. Nat Rev Neurol 2018
32
CGRP may play a causative role in migraine.
L H Lassen, P A Haderslev, V B Jacobsen, H K Iversen, B Sperling, J Olesen. Cephalalgia 2002
L H Lassen, P A Haderslev, V B Jacobsen, H K Iversen, B Sperling, J Olesen. Cephalalgia 2002
30
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial.
Richard B Lipton, David W Dodick, Jessica Ailani, Kaifeng Lu, Michelle Finnegan, Armin Szegedi, Joel M Trugman. JAMA 2019
Richard B Lipton, David W Dodick, Jessica Ailani, Kaifeng Lu, Michelle Finnegan, Armin Szegedi, Joel M Trugman. JAMA 2019
28
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine.
Tiffini Voss, Richard B Lipton, David W Dodick, Nicole Dupre, Joy Yang Ge, Robert Bachman, Christopher Assaid, Sheena K Aurora, David Michelson. Cephalalgia 2016
Tiffini Voss, Richard B Lipton, David W Dodick, Nicole Dupre, Joy Yang Ge, Robert Bachman, Christopher Assaid, Sheena K Aurora, David Michelson. Cephalalgia 2016
27
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine.
David J Hewitt, Sheena K Aurora, David W Dodick, Peter J Goadsby, Yang Joy Ge, Robert Bachman, Donna Taraborelli, Xiaoyin Fan, Christopher Assaid, Christopher Lines,[...]. Cephalalgia 2011
David J Hewitt, Sheena K Aurora, David W Dodick, Peter J Goadsby, Yang Joy Ge, Robert Bachman, Donna Taraborelli, Xiaoyin Fan, Christopher Assaid, Christopher Lines,[...]. Cephalalgia 2011
27
Ubrogepant for the Treatment of Migraine.
David W Dodick, Richard B Lipton, Jessica Ailani, Kaifeng Lu, Michelle Finnegan, Joel M Trugman, Armin Szegedi. N Engl J Med 2019
David W Dodick, Richard B Lipton, Jessica Ailani, Kaifeng Lu, Michelle Finnegan, Joel M Trugman, Armin Szegedi. N Engl J Med 2019
27
The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.
P J Goadsby, L Edvinsson. Ann Neurol 1993
P J Goadsby, L Edvinsson. Ann Neurol 1993
27
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.
. Cephalalgia 2018
. Cephalalgia 2018
26
BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial.
Ronald Marcus, Peter J Goadsby, David Dodick, David Stock, George Manos, Tanya Z Fischer. Cephalalgia 2014
Ronald Marcus, Peter J Goadsby, David Dodick, David Stock, George Manos, Tanya Z Fischer. Cephalalgia 2014
25
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine.
T W Ho, L K Mannix, X Fan, C Assaid, C Furtek, C J Jones, C R Lines, A M Rapoport. Neurology 2008
T W Ho, L K Mannix, X Fan, C Assaid, C Furtek, C J Jones, C R Lines, A M Rapoport. Neurology 2008
24
A Controlled Trial of Erenumab for Episodic Migraine.
Peter J Goadsby, Uwe Reuter, Yngve Hallström, Gregor Broessner, Jo H Bonner, Feng Zhang, Sandhya Sapra, Hernan Picard, Daniel D Mikol, Robert A Lenz. N Engl J Med 2017
Peter J Goadsby, Uwe Reuter, Yngve Hallström, Gregor Broessner, Jo H Bonner, Feng Zhang, Sandhya Sapra, Hernan Picard, Daniel D Mikol, Robert A Lenz. N Engl J Med 2017
24
Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine.
Richard B Lipton, Robert Croop, Elyse G Stock, David A Stock, Beth A Morris, Marianne Frost, Gene M Dubowchik, Charles M Conway, Vladimir Coric, Peter J Goadsby. N Engl J Med 2019
Richard B Lipton, Robert Croop, Elyse G Stock, David A Stock, Beth A Morris, Marianne Frost, Gene M Dubowchik, Charles M Conway, Vladimir Coric, Peter J Goadsby. N Engl J Med 2019
24
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.
Robert Croop, Peter J Goadsby, David A Stock, Charles M Conway, Micaela Forshaw, Elyse G Stock, Vladimir Coric, Richard B Lipton. Lancet 2019
Robert Croop, Peter J Goadsby, David A Stock, Charles M Conway, Micaela Forshaw, Elyse G Stock, Vladimir Coric, Richard B Lipton. Lancet 2019
24
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
Tony W Ho, Michel D Ferrari, David W Dodick, Vince Galet, James Kost, Xiaoyin Fan, Heather Leibensperger, Samar Froman, Christopher Assaid, Christopher Lines,[...]. Lancet 2008
Tony W Ho, Michel D Ferrari, David W Dodick, Vince Galet, James Kost, Xiaoyin Fan, Heather Leibensperger, Samar Froman, Christopher Assaid, Christopher Lines,[...]. Lancet 2008
23
Fremanezumab for the Preventive Treatment of Chronic Migraine.
Stephen D Silberstein, David W Dodick, Marcelo E Bigal, Paul P Yeung, Peter J Goadsby, Tricia Blankenbiller, Melissa Grozinski-Wolff, Ronghua Yang, Yuju Ma, Ernesto Aycardi. N Engl J Med 2017
Stephen D Silberstein, David W Dodick, Marcelo E Bigal, Paul P Yeung, Peter J Goadsby, Tricia Blankenbiller, Melissa Grozinski-Wolff, Ronghua Yang, Yuju Ma, Ernesto Aycardi. N Engl J Med 2017
23
Calcitonin gene-related peptide: physiology and pathophysiology.
F A Russell, R King, S-J Smillie, X Kodji, S D Brain. Physiol Rev 2014
F A Russell, R King, S-J Smillie, X Kodji, S D Brain. Physiol Rev 2014
22
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention.
Tony W Ho, Kathryn M Connor, Ying Zhang, Eric Pearlman, Janelle Koppenhaver, Xiaoyin Fan, Christopher Lines, Lars Edvinsson, Peter J Goadsby, David Michelson. Neurology 2014
Tony W Ho, Kathryn M Connor, Ying Zhang, Eric Pearlman, Janelle Koppenhaver, Xiaoyin Fan, Christopher Lines, Lars Edvinsson, Peter J Goadsby, David Michelson. Neurology 2014
22
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.
Stewart Tepper, Messoud Ashina, Uwe Reuter, Jan L Brandes, David Doležil, Stephen Silberstein, Paul Winner, Dean Leonardi, Daniel Mikol, Robert Lenz. Lancet Neurol 2017
Stewart Tepper, Messoud Ashina, Uwe Reuter, Jan L Brandes, David Doležil, Stephen Silberstein, Paul Winner, Dean Leonardi, Daniel Mikol, Robert Lenz. Lancet Neurol 2017
21
Randomized, controlled trial of telcagepant for the acute treatment of migraine.
K M Connor, R E Shapiro, H-C Diener, S Lucas, J Kost, X Fan, K Fei, C Assaid, C Lines, Tony W Ho. Neurology 2009
K M Connor, R E Shapiro, H-C Diener, S Lucas, J Kost, X Fan, K Fei, C Assaid, C Lines, Tony W Ho. Neurology 2009
20
Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.
Virginia L Stauffer, David W Dodick, Qi Zhang, Jeffrey N Carter, Jessica Ailani, Robert R Conley. JAMA Neurol 2018
Virginia L Stauffer, David W Dodick, Qi Zhang, Jeffrey N Carter, Jessica Ailani, Robert R Conley. JAMA Neurol 2018
20
Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial.
Vladimir Skljarevski, Manjit Matharu, Brian A Millen, Michael H Ossipov, Byung-Kun Kim, Jyun Yan Yang. Cephalalgia 2018
Vladimir Skljarevski, Manjit Matharu, Brian A Millen, Michael H Ossipov, Byung-Kun Kim, Jyun Yan Yang. Cephalalgia 2018
20
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine.
David W Dodick, Messoud Ashina, Jan Lewis Brandes, David Kudrow, Michel Lanteri-Minet, Vera Osipova, Kerry Palmer, Hernan Picard, Daniel D Mikol, Robert A Lenz. Cephalalgia 2018
David W Dodick, Messoud Ashina, Jan Lewis Brandes, David Kudrow, Michel Lanteri-Minet, Vera Osipova, Kerry Palmer, Hernan Picard, Daniel D Mikol, Robert A Lenz. Cephalalgia 2018
19
Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study.
Holland C Detke, Peter J Goadsby, Shufang Wang, Deborah I Friedman, Katherine J Selzler, Sheena K Aurora. Neurology 2018
Holland C Detke, Peter J Goadsby, Shufang Wang, Deborah I Friedman, Katherine J Selzler, Sheena K Aurora. Neurology 2018
19
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: results from a phase II study.
Hans-Christoph Diener, Piero Barbanti, Carl Dahlöf, Uwe Reuter, Julia Habeck, Jana Podhorna. Cephalalgia 2011
Hans-Christoph Diener, Piero Barbanti, Carl Dahlöf, Uwe Reuter, Julia Habeck, Jana Podhorna. Cephalalgia 2011
18
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
David W Dodick, Stephen D Silberstein, Marcelo E Bigal, Paul P Yeung, Peter J Goadsby, Tricia Blankenbiller, Melissa Grozinski-Wolff, Ronghua Yang, Yuju Ma, Ernesto Aycardi. JAMA 2018
David W Dodick, Stephen D Silberstein, Marcelo E Bigal, Paul P Yeung, Peter J Goadsby, Tricia Blankenbiller, Melissa Grozinski-Wolff, Ronghua Yang, Yuju Ma, Ernesto Aycardi. JAMA 2018
17
Wiping Out CGRP: Potential Cardiovascular Risks.
Antoinette MaassenVanDenBrink, Joris Meijer, Carlos M Villalón, Michel D Ferrari. Trends Pharmacol Sci 2016
Antoinette MaassenVanDenBrink, Joris Meijer, Carlos M Villalón, Michel D Ferrari. Trends Pharmacol Sci 2016
16
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura.
Jakob Møller Hansen, Anne Werner Hauge, Jes Olesen, Messoud Ashina. Cephalalgia 2010
Jakob Møller Hansen, Anne Werner Hauge, Jes Olesen, Messoud Ashina. Cephalalgia 2010
16
16
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.
Hong Sun, David W Dodick, Stephen Silberstein, Peter J Goadsby, Uwe Reuter, Messoud Ashina, Joel Saper, Roger Cady, Yun Chon, Julie Dietrich,[...]. Lancet Neurol 2016
Hong Sun, David W Dodick, Stephen Silberstein, Peter J Goadsby, Uwe Reuter, Messoud Ashina, Joel Saper, Roger Cady, Yun Chon, Julie Dietrich,[...]. Lancet Neurol 2016
16
The International Classification of Headache Disorders, 3rd edition (beta version).
. Cephalalgia 2013
. Cephalalgia 2013
16
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study.
Uwe Reuter, Peter J Goadsby, Michel Lanteri-Minet, Shihua Wen, Peggy Hours-Zesiger, Michel D Ferrari, Jan Klatt. Lancet 2018
Uwe Reuter, Peter J Goadsby, Michel Lanteri-Minet, Shihua Wen, Peggy Hours-Zesiger, Michel D Ferrari, Jan Klatt. Lancet 2018
16
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial.
Michel D Ferrari, Hans Christoph Diener, Xiaoping Ning, Maja Galic, Joshua M Cohen, Ronghua Yang, Matthias Mueller, Andrew H Ahn, Yael Carmeli Schwartz, Melissa Grozinski-Wolff,[...]. Lancet 2019
Michel D Ferrari, Hans Christoph Diener, Xiaoping Ning, Maja Galic, Joshua M Cohen, Ronghua Yang, Matthias Mueller, Andrew H Ahn, Yael Carmeli Schwartz, Melissa Grozinski-Wolff,[...]. Lancet 2019
16
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing.
M G Rosenfeld, J J Mermod, S G Amara, L W Swanson, P E Sawchenko, J Rivier, W W Vale, R M Evans. Nature 1983
M G Rosenfeld, J J Mermod, S G Amara, L W Swanson, P E Sawchenko, J Rivier, W W Vale, R M Evans. Nature 1983
15
Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Eva Cernuda-Morollón, Davinia Larrosa, César Ramón, Juan Vega, Pablo Martínez-Camblor, Julio Pascual. Neurology 2013
Eva Cernuda-Morollón, Davinia Larrosa, César Ramón, Juan Vega, Pablo Martínez-Camblor, Julio Pascual. Neurology 2013
15
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.
David W Dodick, Peter J Goadsby, Stephen D Silberstein, Richard B Lipton, Jes Olesen, Messoud Ashina, Kerri Wilks, David Kudrow, Robin Kroll, Bruce Kohrman,[...]. Lancet Neurol 2014
David W Dodick, Peter J Goadsby, Stephen D Silberstein, Richard B Lipton, Jes Olesen, Messoud Ashina, Kerri Wilks, David Kudrow, Robin Kroll, Bruce Kohrman,[...]. Lancet Neurol 2014
15
Calcitonin gene-related peptide (CGRP): a new target for migraine.
Andrew F Russo. Annu Rev Pharmacol Toxicol 2015
Andrew F Russo. Annu Rev Pharmacol Toxicol 2015
14
Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist.
H Doods, G Hallermayer, D Wu, M Entzeroth, K Rudolf, W Engel, W Eberlein. Br J Pharmacol 2000
H Doods, G Hallermayer, D Wu, M Entzeroth, K Rudolf, W Engel, W Eberlein. Br J Pharmacol 2000
14
Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25.
Debbie L Hay, Michael L Garelja, David R Poyner, Christopher S Walker. Br J Pharmacol 2018
Debbie L Hay, Michael L Garelja, David R Poyner, Christopher S Walker. Br J Pharmacol 2018
14
Migraine--current understanding and treatment.
Peter J Goadsby, Richard B Lipton, Michel D Ferrari. N Engl J Med 2002
Peter J Goadsby, Richard B Lipton, Michel D Ferrari. N Engl J Med 2002
13
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.
David W Dodick, Peter J Goadsby, Egilius L H Spierings, Joel C Scherer, Steven P Sweeney, David S Grayzel. Lancet Neurol 2014
David W Dodick, Peter J Goadsby, Egilius L H Spierings, Joel C Scherer, Steven P Sweeney, David S Grayzel. Lancet Neurol 2014
13
Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
. Lancet Neurol 2018
. Lancet Neurol 2018
13
Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine.
Tony W Ho, Andrew P Ho, Yang Joy Ge, Christopher Assaid, Regina Gottwald, E Anne MacGregor, Lisa K Mannix, Willebrordus P J van Oosterhout, Janelle Koppenhaver, Christopher Lines,[...]. Cephalalgia 2016
Tony W Ho, Andrew P Ho, Yang Joy Ge, Christopher Assaid, Regina Gottwald, E Anne MacGregor, Lisa K Mannix, Willebrordus P J van Oosterhout, Janelle Koppenhaver, Christopher Lines,[...]. Cephalalgia 2016
20
Pharmacologic Characterization of AMG 334, a Potent and Selective Human Monoclonal Antibody against the Calcitonin Gene-Related Peptide Receptor.
Licheng Shi, Sonya G Lehto, Dawn X D Zhu, Hong Sun, Jianhua Zhang, Brian P Smith, David C Immke, Kenneth D Wild, Cen Xu. J Pharmacol Exp Ther 2016
Licheng Shi, Sonya G Lehto, Dawn X D Zhu, Hong Sun, Jianhua Zhang, Brian P Smith, David C Immke, Kenneth D Wild, Cen Xu. J Pharmacol Exp Ther 2016
12
Migraine and the trigeminovascular system-40 years and counting.
Messoud Ashina, Jakob Møller Hansen, Thien Phu Do, Agustin Melo-Carrillo, Rami Burstein, Michael A Moskowitz. Lancet Neurol 2019
Messoud Ashina, Jakob Møller Hansen, Thien Phu Do, Agustin Melo-Carrillo, Rami Burstein, Michael A Moskowitz. Lancet Neurol 2019
12
Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1).
Messoud Ashina, Joel Saper, Roger Cady, Barbara A Schaeffler, David M Biondi, Joe Hirman, Susan Pederson, Brent Allan, Jeff Smith. Cephalalgia 2020
Messoud Ashina, Joel Saper, Roger Cady, Barbara A Schaeffler, David M Biondi, Joe Hirman, Susan Pederson, Brent Allan, Jeff Smith. Cephalalgia 2020
12
Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products.
S G Amara, V Jonas, M G Rosenfeld, E S Ong, R M Evans. Nature 1982
S G Amara, V Jonas, M G Rosenfeld, E S Ong, R M Evans. Nature 1982
12
Gepants for the treatment of migraine.
Andrea Negro, Paolo Martelletti. Expert Opin Investig Drugs 2019
Andrea Negro, Paolo Martelletti. Expert Opin Investig Drugs 2019
18
Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion.
S Eftekhari, C A Salvatore, A Calamari, S A Kane, J Tajti, L Edvinsson. Neuroscience 2010
S Eftekhari, C A Salvatore, A Calamari, S A Kane, J Tajti, L Edvinsson. Neuroscience 2010
11
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.